1) API Quality
Stiripentol API is produced under stringent quality systems to ensure exceptional purity, stability, and therapeutic reliability. Each batch goes through validated manufacturing processes and advanced analytical testing to comply with international pharmacopeial standards. Its consistent performance makes it suitable for formulations used in managing refractory epileptic disorders, especially Dravet syndrome.

2) Comprehensive Documentation
A complete and well-structured documentation package is provided to support global regulatory submissions. This includes DMF, COA, MSDS, stability data, impurity profiles, analytical method validation, and technical dossiers. The documents are designed to simplify audits, accelerate regulatory approvals, and ensure full compliance across international markets.

3) Secure Supply Chain
A robust and traceable supply chain ensures the continuous availability of Stiripentol API. From reliable sourcing of raw materials to controlled manufacturing and efficient global logistics, every stage is closely monitored to maintain product integrity. This secure supply framework supports long-term production planning with minimal disruption.

4) Manufacturer & Supplier Expertise
Produced in WHO-GMP-certified facilities, Stiripentol API benefits from advanced production technologies, skilled chemists, and optimized quality systems. Strong manufacturing expertise ensures high-capacity output, consistent batch performance, and adherence to global regulatory standards, making the API suitable for both domestic and international markets.

5) Amber Lifesciences’ Role
Amber Lifesciences plays a key role in offering premium-quality Stiripentol API supported by robust quality management and technical excellence. Amber ensures reliable documentation, consistent product quality, and secure global distribution, making it a trusted partner for pharmaceutical companies seeking dependable antiepileptic API solutions.